Cyclopharm Ltd CYCMF
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- $0.00 / —
- Market Cap
- $180.59 Mil
- Volume/Avg
- 111,100 / 111,100
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Cyclopharm Ltd is a company that engages in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development. It operates through the following segments. The Technegas segment involves supplying diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism, and a distributor of products to the diagnostic imaging sector. The Molecular Imaging segment offers to produce radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders, and cardiac disease. The firm generates maximum revenue from the Technegas segment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 63
- Website
- https://cyclopharm.com.au
Comparables
Valuation
|
Metric
|
CYCMF
|
603387
|
688656
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 24.57 | 35.29 |
Price/Book Value | — | 1.80 | 1.92 |
Price/Sales | — | 3.66 | 4.03 |
Price/Cash Flow | — | 12.34 | 14.84 |
Price/Earnings
CYCMF
603387
688656
Financial Strength
|
Metric
|
CYCMF
|
603387
|
688656
|
|---|---|---|---|
Quick Ratio | 2.26 | 1.56 | 1.01 |
Current Ratio | 3.48 | 2.22 | 1.81 |
Interest Coverage | −20.66 | 16.13 | 21.54 |
Quick Ratio
CYCMF
603387
688656
Profitability
|
Metric
|
CYCMF
|
603387
|
688656
|
|---|---|---|---|
Return on Assets (Normalized) | −13.73% | 5.99% | 4.79% |
Return on Equity (Normalized) | −18.60% | 8.72% | 5.68% |
Return on Invested Capital (Normalized) | −16.80% | 5.29% | 5.34% |
Return on Assets
CYCMF
603387
688656
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Lqwhbjqy | Vmccvm | $184.2 Bil | |
SYK
| Stryker Corp | Prqbkhynjz | Lyzjn | $125.1 Bil | |
MDT
| Medtronic PLC | Stgjcnbcm | Mvzvt | $108.5 Bil | |
BSX
| Boston Scientific Corp | Dxdkgyd | Rgbcxr | $107.1 Bil | |
EW
| Edwards Lifesciences Corp | Msnrtjqsp | Skjbjdn | $51.4 Bil | |
DXCM
| DexCom Inc | Mswkwzjzz | Kbcb | $50.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Sfwzwbbbg | Wzzhn | $25.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Knkjcvdw | Hlbxfnw | $24.4 Bil | |
ALGN
| Align Technology Inc | Lwtymdkj | Scsfv | $21.7 Bil | |
PODD
| Insulet Corp | Hcsfjbshf | Nlhqtx | $12.2 Bil |